Does Ivermectin Cause Diarrhea and What to Do?

Ivermectin can cause diarrhea, but it does so less often than most people expect. In clinical studies at standard prescription doses, diarrhea shows up in a small percentage of patients and tends to be mild and short-lived. The picture gets more complicated when you factor in that ivermectin is usually taken to treat a parasite, and the parasite itself often causes diarrhea that the drug then resolves. Sorting out whether ivermectin is causing your gut symptoms or relieving them matters for deciding what to do next.

How Common Is Diarrhea at Standard Doses

The actual incidence of ivermectin-related diarrhea in clinical trials is low. A meta-analysis of over a thousand children treated with ivermectin for parasitic infections found diarrhea in about 0.4% of those treated, making it one of the less frequent side effects alongside headache and vomiting.¹ None of the adverse events in that analysis were classified as serious.

Randomized, placebo-controlled trials in adults have painted a similar picture. In two double-blinded trials comparing ivermectin to placebo in COVID-19 patients, diarrhea rates were virtually identical between the ivermectin and placebo groups, with no statistically significant difference at any time point.² That finding is telling: when researchers use a placebo comparison and the drug is not being given for a gut-dwelling parasite, ivermectin does not appear to cause diarrhea at rates beyond what people experience from the placebo alone.

So if you have taken a standard dose of ivermectin and develop loose stools, the drug itself is one possible explanation but far from the only one. Anxiety, dietary changes, and the underlying infection being treated all contribute to gut symptoms around the time of dosing.

Why Ivermectin Can Affect Your Gut

Ivermectin is a highly fat-soluble compound that gets absorbed in the small intestine and reaches meaningful concentrations in the gut wall. Animal research has shown that ivermectin, particularly at higher or repeated doses, can alter gastrointestinal motility and the physical structure of the intestinal wall. In rats, three consecutive doses impaired gastrointestinal function and morphology, affecting gastric emptying and intestinal transit even in uninfected animals.³ Higher doses produced more pronounced changes. This is one reason a single standard dose is unlikely to cause much trouble, while repeated or excessive dosing raises the risk of gut symptoms.

The drug works by binding to certain chloride channels in invertebrate nerve and muscle cells, which is how it paralyzes worms. Mammals share some related channels in the gut’s smooth muscle, and at high enough local concentrations, ivermectin can nudge intestinal transit in ways that translate to cramping or loose stools. At a properly dosed single treatment, these effects tend to be minimal in most people.

Parasite Die-Off Can Look Like a Side Effect

Here is the wrinkle that confuses a lot of patients and even some clinicians: ivermectin is most commonly prescribed to kill parasites living in or passing through your intestines, and the death of those parasites triggers its own set of symptoms. In patients with strongyloidiasis, a common thread-worm infection, about half had diarrhea before treatment, and it resolved after ivermectin cleared the parasite.⁴ In those cases, diarrhea was a symptom of the disease, not the cure.

For filarial infections like onchocerciasis (river blindness), there is an additional layer. When ivermectin kills large numbers of microfilariae, the body can mount an inflammatory reaction called a Mazzotti reaction, which includes itching, rash, fever, swelling, and abdominal pain.⁵ The abdominal pain and general inflammatory response can include diarrhea, but it is the immune system reacting to dead parasites rather than a direct toxic effect of the drug. Mazzotti reactions correlate with how heavily someone is infected, and they typically peak within the first day or two after treatment.

If you are being treated for a parasitic infection and develop diarrhea shortly after your dose, the most likely explanation is the infection clearing, not the drug hurting your gut. This distinction matters because it usually means the drug is working.

What Ivermectin Does to Gut Bacteria

Any drug that passes through the intestines has the potential to shake up the microbial ecosystem living there. Ivermectin has been studied for this, and the findings are reassuring at normal doses. An in vitro experiment simulating human gut conditions found that short-duration ivermectin exposure introduced only minor, temporary shifts in microbial composition and metabolite production. The researchers concluded that a standard course would not be expected to cause dysbiosis or gut-related side effects in healthy adults.⁶

Dose matters here, though. A metagenomics study looking at people treated with anthelmintic combinations found that those receiving higher absolute ivermectin doses, roughly 15 mg or more, showed more pronounced changes in the types and functions of their gut bacteria.⁷ The drug’s resistance profile of the microbiome stayed mostly stable, which is good news, but the functional and compositional shifts at higher doses could contribute to temporary digestive upset. People who are larger and therefore receive higher absolute doses may experience more of this effect.

How Dose and How You Take It Change the Picture

Ivermectin is weight-based: the standard antiparasitic dose is typically around 150 to 200 micrograms per kilogram. At that range, gastrointestinal side effects are uncommon. But the drug’s absorption is strongly influenced by whether you take it with food, and that changes how much of it ends up in your system. Pharmacokinetic modeling shows that ivermectin’s absorption depends heavily on bile-mediated solubility, and eating, particularly a fatty meal, increases the amount of drug that reaches your bloodstream by roughly 20% or more.⁸⁹

This is worth knowing for two reasons. First, if your prescriber tells you to take ivermectin on an empty stomach (which is common for certain parasitic indications), that instruction is partly about controlling absorption and limiting side effects. Taking it with a large fatty meal could push your effective exposure higher, which might tip someone on the edge into experiencing gut symptoms. Second, body mass index appears to influence plasma exposure, meaning that people with higher BMI may handle the drug differently than leaner individuals at the same weight-based dose.⁹

At doses well beyond what is prescribed, gastrointestinal symptoms become more predictable. In cases of ivermectin toxicity, including people who took veterinary formulations during the COVID-19 pandemic, gastrointestinal symptoms were among the most frequently reported problems alongside neurological effects.¹⁰¹¹ At those doses, diarrhea, nausea, and vomiting are not surprising: the gut is being exposed to concentrations the human body was never meant to handle.

Why Loperamide Is Not a Simple Fix

If you develop diarrhea after ivermectin, reaching for an over-the-counter anti-diarrheal like loperamide (the active ingredient in many common brands) seems logical. It works by slowing intestinal transit, which gives the colon more time to absorb water and firms up stools. But ivermectin and loperamide share a meaningful interaction that most people are unaware of.

Both drugs are substrates of a transporter protein called P-glycoprotein, which acts as a gatekeeper at important barriers in the body, including the blood-brain barrier and the intestinal wall. When loperamide slows gut transit, it gives the intestines more time to absorb ivermectin, markedly increasing ivermectin’s plasma concentrations. Rat studies found significantly higher ivermectin levels in the blood, liver, and intestinal wall when loperamide was co-administered, likely because the delayed transit extended the window for absorption and because both drugs compete for the same efflux pumps.¹²

Higher ivermectin plasma levels mean a greater chance of dose-dependent side effects, including more gut distress and, in a worst case, neurological toxicity. P-glycoprotein also limits how much ivermectin crosses into the brain; anything that compromises this pump raises the risk of central nervous system effects.¹³ This does not mean loperamide is absolutely off limits after ivermectin, but you should not casually pop it the same day you take your dose without talking to your prescriber first. If diarrhea is mild, simple rehydration and a bland diet are safer first-line strategies.

Other Drug Interactions That Raise Risk

The loperamide interaction is just one piece of a larger pattern. Ivermectin is primarily broken down by a liver enzyme called CYP3A4 and is shuttled out of cells by P-glycoprotein and related transporter proteins. Any medication that strongly inhibits or induces these enzymes or transporters can change how much ivermectin stays in your system and for how long.¹⁴

Some common examples that warrant caution:

CYP3A4 inhibitors: Certain antifungals, macrolide antibiotics, and grapefruit juice can slow the breakdown of ivermectin, effectively raising the dose your body sees.
P-glycoprotein inhibitors: Beyond loperamide, drugs like verapamil, cyclosporine, and some HIV protease inhibitors can reduce the efflux of ivermectin from cells, again raising tissue concentrations.
CYP3A4 inducers: Rifampin, certain anti-seizure medications, and St. John’s wort can speed up ivermectin metabolism, potentially reducing its effectiveness against the target parasite rather than increasing side effects.

Genetic variation adds another layer. Some people carry polymorphisms in the genes encoding CYP3A4 or P-glycoprotein (also known as MDR1 or ABCB1) that make them naturally slower at clearing ivermectin. These individuals can experience higher drug exposure from a standard dose.¹⁴ If you have ever been told you are a “slow metabolizer” or have had unusual reactions to other medications that share these pathways, mention it to your doctor before taking ivermectin.

When to Seek Medical Attention

Mild, self-limiting diarrhea that begins within a day of taking a prescribed dose of ivermectin and resolves within 24 to 48 hours is generally not a cause for alarm. Stay hydrated, eat bland foods, and let your body do its work. If you are being treated for a parasitic infection, temporary gut symptoms are often a sign of the infection clearing rather than the drug causing harm.

Seek medical attention promptly if you experience any of the following after taking ivermectin:

Persistent or severe diarrhea: More than a couple of days, or severe enough to cause dehydration, particularly in children, older adults, or anyone with chronic illness.
Neurological symptoms: Confusion, difficulty walking, visual changes, tremor, or unusual drowsiness. These suggest ivermectin is reaching the brain, which can happen with overdose or with compromised P-glycoprotein function.¹⁵
Signs of a Mazzotti reaction: High fever, widespread rash, rapid heartbeat, or low blood pressure developing within hours of a dose, especially if you are being treated for a filarial infection and have a heavy parasite burden.⁵
Known or suspected overdose: Anyone who has taken a veterinary formulation or a dose substantially higher than what was prescribed should contact a poison control center or emergency room immediately, as gastrointestinal symptoms in that context often accompany more dangerous neurological and cardiovascular effects.¹¹

Practical Steps for Managing Mild Symptoms

For run-of-the-mill loose stools after a standard prescription dose, here is what actually helps:

Stay hydrated: Water, oral rehydration solutions, or diluted broth. Diarrhea’s main danger is fluid and electrolyte loss, not the diarrhea itself.
Eat simply: Rice, toast, bananas, and other low-residue foods can help settle things while your gut recovers.
Avoid fatty meals around dosing: Since fat increases ivermectin absorption, eating a heavy meal alongside or shortly before your dose can amplify both the drug’s systemic levels and the odds of GI discomfort.⁸ Follow your prescriber’s instructions about whether to take it with food or on an empty stomach.
Hold off on anti-diarrheals: As discussed, loperamide can raise ivermectin levels. If symptoms are manageable, let the diarrhea run its course. If it is severe enough that you feel you need medication, call your prescriber rather than self-treating.
Monitor for escalation: Keep an eye out for the red flags above, especially in the first 48 hours. Most people sail through a single dose with no issues at all.

The Veterinary Formulation Problem

During the COVID-19 pandemic, ivermectin use surged in ways that regulators had not anticipated. The FDA issued warnings about people self-medicating with veterinary ivermectin products, which come in much higher concentrations than human formulations and are meant for animals weighing hundreds of kilograms.¹⁶ Poison control data from this period showed that gastrointestinal symptoms were among the most commonly reported complaints, along with neurological problems and muscle pain.¹⁰

Veterinary paste formulations are not designed for precise human dosing. The concentration per unit volume is far higher, the inactive ingredients differ, and the delivery mechanism assumes you are dosing a horse. People who used these products were essentially guaranteeing themselves a significant overdose. Severe diarrhea, vomiting, and abdominal cramping were among the milder outcomes; some cases involved serious neurological toxicity requiring hospitalization.¹¹ If someone you know has taken a veterinary product and is experiencing GI symptoms, do not assume it will pass on its own. Get medical help.

The lesson from that episode is not that ivermectin is a dangerous drug. When prescribed appropriately for approved indications at the correct dose, it has a strong safety record spanning decades of mass drug administration programs in tropical medicine. The lesson is that concentration and dose matter enormously, and that GI symptoms after taking a non-prescribed ivermectin product warrant a very different level of concern than a touch of loose stools after a standard prescription.

1
PLOS Neglected Tropical Diseases. A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?
2
Frontiers in Medicine. Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials
3
Elsevier / ScienceDirect. Gastrointestinal effects of ivermectin treatment in rats infected with Strongyloides venezuelensis
4
PLOS Neglected Tropical Diseases. Efficacy and Safety of Single and Double Doses of Ivermectin versus 7-Day High Dose Albendazole for Chronic Strongyloidiasis
5
PLOS Neglected Tropical Diseases. Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World
6
PubMed Central. Impact of Ivermectin on the Gut Microbial Ecosystem
7
npj Biofilms and Microbiomes. Combined high-quality metagenomics reveals off-target effects of albendazole, ivermectin-albendazole and moxidectin-albendazole on the human gut bacteria
8
Journal of Antimicrobial Chemotherapy. The effect of food on the pharmacokinetics of oral ivermectin
9
PubMed Central. PBPK modeling of ivermectin-Considerations for the purpose of developing alternative routes to optimize its safety profile
10
PubMed. Characteristics of ivermectin toxicity in patients taking veterinary and human formulations for the prevention and treatment of COVID-19
11
PubMed Central. Identifying the Toxidrome of Ivermectin Toxicity
12
PubMed. Loperamide modifies the tissue disposition kinetics of ivermectin in rats
13
PubMed Central. Ivermectin: does P-glycoprotein play a role in neurotoxicity?
14
PubMed Central. Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects
15
PubMed Central. Ivermectin Toxicity in Humans and Animals: Clinical Spectrum, Mechanisms, and Management
16
PubMed Central. Repurposing the drug, ivermectin, in COVID-19: toxicological points of view